iconstar paper   HIV Articles  
Back grey arrow rt.gif
 
 
50,000 monkeypox vax appointments-NYC online Friday
 
 
  Over 50,000 additional first- and second-dose appointments will be made available at 4 p.m. Friday.
 
For more information, including how to schedule an appointment, click here.
 
https://www.cbsnews.com/newyork/news/monkeypox-vaccine-eligibility-second-doses/
 
Get Vaccinated
 
First- and second-dose appointments are now available. Walk-in vaccinations for first doses are also available at City-run sites, but we recommend you make an appointment. Effective September 16 at 4 p.m., you can get a second dose appointment as long as it has been at least 28 days after your first dose. You must make an appointment to get a second dose.
 
If you are eligible, you can make an appointment by clicking on the button below, or by calling 877-VAX-4NYC (877-829-4692).
 
Monkeypox Vaccination Appointments
 
Second Doses
 
Second-dose appointments are now available. Effective September 16 at 4 p.m., you can get a second dose at least 28 days after your first dose.
 
You will start to build protection in the days and weeks after your first dose, but you will not have full immunity from the vaccine until two weeks after the second dose. You can get a second dose intradermally even if you got your first dose subcutaneously. If you had monkeypox, then you likely have some protection against another infection and are currently not eligible for a first or second dose of the vaccine at this time.
 
Intradermal Injections
 
To make more doses available, the federal government has mandated the vaccine now be given intradermally - into an outer layer of skin (dermis). This method allows us to get four to five times more doses from the same amount of supply. Evidence has shown this approach will provide similar protection as subcutaneous injections, which are made into the deepest layer of skin.
 
Due to potential differences in side effects for the two injection methods, the CDC recommends people who have had keloid scars receive a subcutaneous injection. The risk for these types of reactions is higher for people with darker skin. Those who have a history of keloid formation will be allowed to request a subcutaneous injection at the vaccination site.
 
Intradermal Administration of the JYNNEOS Vaccine (PDF)

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org